Outsourced Pharma App Notes & Case Studies

  1. Designing Agile Manufacturing With An Integrated Drug Substance/Drug Product Ecosystem 9/3/2021

    Companies that want to accelerate their biomanufacturing operations and use their resources efficiently need access to technologies and solutions that can safely and efficiently complete their workflow from idea to injection.

  2. For mAbs, A Small Biotech Recognizes The Value In Lonza’s Expertise And Track Record 9/7/2021

    William B. Jones, Senior Vice President of Pharmaceutical Development at Corvus Pharmaceuticals, discusses his company’s selection of CDMO for its CPI-006 antibody program, which is currently under development as an oncology drug and investigation as a therapeutic for immune disorders and infectious diseases.

  3. Developing A Continuous Large-Scale Perfusion Cell Culture Process 9/25/2020

    The key benefits of perfusion processes are compact process design, flexibility, increased productivity, increased yield, and consistent product quality. 

  4. Saving Development Time And Economizing Distribution With A Single-Vendor Approach 7/29/2021

    By minimizing the overall time, complexity, and effort of clients’ projects and reducing the risks, Thermo Fisher’s most complete integrated offering represents a strong single-vendor solution.

  5. Meet The Scientist — Bryan Braxton, Ph.D. 2/5/2021

    Bryan Braxton has a friendly, grounded demeanor and a scientific mind that creates solutions for our most complex aseptic development projects. But how did these two traits combine in the same person?

  6. Science Of Scale For Spray Dried Intermediates 9/2/2020

    Significant interest has been focused on the science of scale for spray drying. This paper identifies critical steps that can smooth the development pathway, eliminating scale-up headaches down the road.

  7. How Digitization Is Delivering Competitive Advantage In Device Assembly 9/20/2021

    Data and the digitization of assembly equipment work together to deliver competitive advantage to pharma partners in terms of product quality, continuous improvement, de-risking maintenance and change management, and the ability to deliver unique identities and traceability for every assembled device.

  8. In Vitro Test Methodologies To Characterize Bioavailability Enhancing Formulations 7/23/2020

    Some of the most important technologies available to formulators are those that enhance bioavailability, given the large percentage of low-solubility compounds in today’s pharmaceutical pipelines. Formulators have many choices in their toolkit when it comes to bioavailability enhancement, so the tough call becomes which one to use for a given compound. Lonza has developed a full complement of tools that accurately predict the performance of bioavailability-enhanced formulations.

  9. Zydis® ODT Provides Better Treatments 12/18/2019

    Discover how Catalent's oral drug delivery offerings can help get your molecule to market faster. In this case study, learn the many benefits of our product offerings.

  10. Manufacturing Vaccines During COVID-19: CMOs/CDMOs To The Rescue 7/16/2021

    Understand what goes into producing a vaccine, raw materials, technology, and a complex manufacturing process, and how and why CMOs and CDMOs are better positioned to bridge the gap between vaccine demand and supply, safely and at speed.